regeneron glp-1 BioCentury Regeneron’s George Yancopoulos talks GLP-1

Nausea is one of the most commonly reported side effects associated with injectable weight loss medications, particularly those in the glucagon-like peptide-1 (GLP-1) receptor agonist class

Tirzepatide, with its shorter five-day half-life, drops faster between doses

You dont know where theyre coming from. Peptides are chains of amino acids

"We expected there might be some stigma around using a GLP-1," Erin Standen, assistant professor of psychological sciences at Rice University, said in a statement

Efficacy and safety of liraglutide versus placebo as add-on to glucose-lowering therapy in patients with type 2 diabetes and moderate renal impairment (LIRA-RENAL): a randomized clinical trial